Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China

Abstract Background Anti-PD-1 antibodies have been approved for treating several cancer. However, data regarding the safety and efficacy of these agents in HIV-infected patients with cancer is lacking, because these patients are frequently omitted from clinical trials. Objectives The primary aim of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luling Wu, Jie Su, Junyang Yang, Ling Gu, Renfang Zhang, Li Liu, Hongzhou Lu, Jun Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-05-01
Colecção:	Infectious Agents and Cancer
Assuntos:	HIV Cancer PD-1 ICIs Safety and outcomes
Acesso em linha:	https://doi.org/10.1186/s13027-023-00512-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!